RJVA-002

N/A

Report date: 2026/04/07 20:00:20

Base Information

Drug NameRJVA-002

Drug Alias NameRJVA-002

ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vectorBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionGlucose-Dependent Insulinotropic Polypeptide Receptor agonistsGlucagon-like peptide 1 receptor agonists

TargetsGlucose-Dependent Insulinotropic Polypeptide ReceptorGlucagon-like peptide 1 receptor

Therapy Area/IndicationsObesity

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesFractyl Health Inc

China Registration ClassN/A

Develop Information

Active CompaniesFractyl Health Inc

Inactive CompaniesN/A

Active IndicationsObesity

Inactive IndicationsN/A

Other Information

ATC CodeN/A